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Chlamydophila abortus is one of the major causes of infectious abortion in pregnant sheep (enzootic abortion
of ewes or EAE) worldwide. Organisms shed in infected placentas and uterine discharges at lambing time are
the main sources of environmental contamination, responsible for transmission to susceptible animals and
possible human contacts. In the present study, a recently developed test, based on a recombinant fragment of
the polymorphic outer membrane protein POMP90 (rOMP90-4 indirect enzyme-linked immunosorbent assay
[iELISA]) and one based on the variable segment 2 (VS2) region of the major outer membrane protein
(MOMP) (MOMP VS2 iELISA) were compared using sera from C. abortus-infected ewes at different stages
throughout pregnancy. The rOMP90 iELISA detected antibody much earlier in pregnancy than the MOMP
iELISA, which, like the complement fixation test, detected antibody only at the time of abortion or lambing. No
anti-MOMP antibody response could be detected in three of seven experimentally infected ewes. Furthermore,
the rOMP90 iELISA detected antibody in an animal that seroconverted during the course of the study, which
the MOMP iELISA failed to detect. Overall, the results show that the rOMP90-4 iELISA is considerably more
sensitive than the MOMP VS2 iELISA for identifying animals infected with C. abortus. Earlier detection of
infection will allow appropriate control measures to be taken to reduce environmental contamination, thus
limiting the spread of infection, financial losses, and the possible risks of zoonotic transmission to humans.
Chlamydiaceae species cause a wide variety of acute and
chronic diseases in animals and humans, including reproduc-
tive disorders (e.g., Chlamydophila abortus, Chlamydophila pe-
corum, Chlamydia trachomatis, and Chlamydia suis), respira-
tory disease (e.g., Chlamydophila pneumoniae, Chlamydophila
psittaci, and C. suis), conjunctivitis (e.g., C. trachomatis,
Chlamydophila felis, and C. pecorum), and arthritis and enteric
infections (C. pecorum) (21). The animal pathogens C. abortus
and C. psittaci are also known to cause zoonotic infections in
humans and so are of considerable public health significance
(21).
C. abortus is the most common cause of infectious abortion
in sheep (enzootic abortion of ewes [EAE]) and goats in the
United Kingdom, resulting in major economic losses (1). The
disease is characterized by acute placentitis, and abortion usu-
ally occurs 2 to 3 weeks before the end of gestation, resulting
in the expulsion of dead or weak lambs. Excreted organisms
shed in infected placentae and uterine discharges contaminate
the environment, and susceptible sheep most probably contract
the disease through ingestion or inhalation of C. abortus-in-
fected material at this time (5, 38). In nonpregnant animals the
organism can exist in a latent or silent form, possibly in lym-
phoid tissue (12, 18), where it remains until at least the onset
of pregnancy. The infection exists at a subclinical level
throughout pregnancy, although pathological changes start to
develop in the placenta after day 90 of gestation (9). Infection
cannot be detected either serologically or by direct detection of
the pathogen (e.g., modified Ziehl-Neelsen staining [36], PCR,
etc.) until the time of abortion, when infectious organisms are
excreted and maternal titers of antibody to C. abortus rapidly
increase, which coincides with the development of protective
immunity. Although ewes develop immunity and do not expe-
rience further C. abortus-induced abortions, they may continue
to excrete infectious organisms during estrus or subsequent
lambings (29), thereby continuing to contaminate the environ-
ment and spread infection.
The most widely accepted serological test for diagnosing
EAE is the complement fixation test (CFT) (35). In the United
Kingdom and elsewhere, the CFT is used by national veteri-
nary laboratories to screen and accredit sheep and goats as
being EAE free. However, the CFT can be insensitive and
lacks specificity (20, 26). In particular, antigenic cross-reactiv-
ity with C. pecorum, as well as with other gram-negative bac-
teria, such as Acinetobacter spp., complicates the interpretation
of results. Other serological tests, based on chlamydial antigen
preparations (2, 10, 11, 26) and purified chlamydial lipopoly-
saccharide (15, 36) have been reported but lack specificity
because they are based on cross-reactive antigens. Other more
sensitive and specific tests based on a C. abortus major outer
membrane protein (MOMP)-specific monoclonal antibody
(31), and recombinant protein fragments of the MOMP (vari-
able segment 2 [VS2] MOMP indirect enzyme-linked immu-
nosorbent assay [iELISA]) (16) and polymorphic outer mem-
brane proteins (ELISAr-Chlamydia and rOMP91B iELISA)
(7, 24) have been developed. More recently, we have reported
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the development of an iELISA based on a recombinant protein
fragment of POMP90 (rOMP90-4 iELISA) (22). The
rOMP90-4 test was found to be more sensitive and specific
than the CFT or rOMP91B iELISA for differentiating between
animals infected with C. abortus and C. pecorum.
The aim of this study was to compare the sensitivities of the
rOMP90-4 and MOMP VS2 iELISAs for detecting chlamydial
antibodies in C. abortus-infected pregnant ewes at different
stages throughout pregnancy. This was achieved by conducting
a retrospective analysis of serum samples derived from a preg-
nant-ewe challenge experiment to characterize the inflamma-
tory immune response to C. abortus infection in the placenta
(8). The potential of each antigen for use as a diagnostic
reagent for detecting EAE is discussed.
MATERIALS AND METHODS
Experimental infection of pregnant ewes. C. abortus isolate S26/3 (28) was
grown in McCoy cells in complete RPMI medium (Life Technologies Ltd.,
Paisley, United Kingdom) and stored in Chlamydia transport medium (SPG [0.25
M sucrose, 10 mM sodium phosphate, 5 mM glutamic acid, pH 7.2]) (33) at
70°C. The inoculum was diluted in phosphate-buffered saline prior to inocu-
lation of pregnant ewes as described previously (8).
Fourteen 5- to 6-year-old Scottish Blackface ewes were group mated with
Suffolk rams. All ewes were seronegative to C. abortus by the CFT and by
immunoblot analysis against whole chlamydial elementary bodies (EBs). Gesta-
tional age was estimated to the nearest week. At 10 weeks of gestation (wg),
seven pregnant ewes were each inoculated by subcutaneous injection over the
left prefemoral lymph node with 2  106 inclusion forming units of C. abortus
(group A). The remaining seven ewes served as uninfected controls and were
each inoculated with a similar volume of uninfected McCoy cell lysate in RPMI
medium (group B). Both the challenged and control animals were each divided
into two groups and housed in separate pens. Ewes were allowed to continue
through to abortion or lambing. Placentas were collected and macroscopically
assessed for EAE lesions, and representative cotyledons were removed for bac-
teriological and pathological analysis. Sheep were bled before, during, and after
pregnancy for serological analysis. The care and use of experimental animals
were approved by the Institute’s Experiments and Ethical Review Committee
and complied with both Home Office Regulations and all local animal welfare
policies.
Bacteriological analysis. Following abortion or lambing, smears of placental
membranes were prepared, stained by the modified Ziehl-Neelsen method, and
examined under high-power microscopy for the presence of EBs (34). To attempt
growth of chlamydial organisms in cell culture, placental cotyledons were asep-
tically ground in SPG and dilutions (1/60) prepared in complete RPMI medium
containing 1 g/ml cycloheximide (Sigma-Aldrich Company Ltd., Poole, United
Kingdom). Diluted material was inoculated onto confluent McCoy cell mono-
layers grown in complete RPMI medium on coverslips in trac bottles (Bibby
Sterilin Ltd., Stone, United Kingdom). The bottles were centrifuged at 3,000 
g at room temperature for 2  15 min and incubated at 37°C in 5% CO2. After
72 h, coverslips were fixed in methanol, stained by Giemsa Gurr (Merck Ltd.,
Poole, United Kingdom), and examined for the presence of chlamydial inclu-
sions by light microscopy.
Antigen production. The rOMP90-4 antigen fragment was cloned into expres-
sion vector pGEX-4T-1, expressed as a soluble glutathione S-transferase (GST)
fusion protein, and purified as described previously (22). Variable segment 1
(VS1) to VS4 of the MOMP-encoding gene were cloned into expression vector
pGEX-2T (16), expressed as GST fusion proteins, and purified as described for
rOMP90-4. Primers were engineered with BamHI/SmaI and EcoRI restriction
enzyme sites (underlined; see below) to allow cloning in frame into the expres-
sion vector. The primer pairs used to generate MOMP VS1 were 5-GATGGA
TCCAAAACTATCACCGGCATGGGT-3 and 5-GCAGAATTCAACCATT
CGGCGTCTTGTAAG-3; those used to generate MOMP VS2 were 5-AGCC
CCGGGTGCGGCATTCAACCTCGTTG-3 and 5-ACAGAATTCGAGAAT
GTTGTATCTGTATAAAATTC-3; those used to generate MOMP VS3 were
5-GCGGGATCCGGAGCAGAGTTCCAATACGC-3 and 5-TGCGAATTC
TGGTATTTAATTGTAGCCGACT-3; and those used to generate MOMP
VS4 were 5-GTAGGATCCTCACGAGCAACTTTTGATGC-3 and 5-TTCG
AATTCTTGATCTGAATCGAAGCAAT-3. GST alone was also expressed
from the empty vector (i.e., no insert) for use as a GST background control in the
iELISAs. Protein concentrations were determined by densitometry of sodium
dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis gels with bovine serum
albumin standards using a GS-670 imaging densitometer (Bio-Rad Laboratories
Ltd., Hemel Hempstead, United Kingdom).
Immunoblotting. C. abortus S26/3 EBs, purified from infected McCoy cells as
described previously (28), and recombinant MOMP and POMP antigens were
subjected to SDS-polyacrylamide gel electrophoresis after boiling in sample
buffer containing 2% SDS and 5% 2-mercaptoethanol. Protein was transferred to
nitrocellulose by semidry blotting and blocked with 5% nonfat dried milk
(NFDM)–Tris-buffered saline, pH 7.6, overnight at 4°C. Blots were incubated
with sheep sera diluted 1/100 in Tris-buffered saline–0.1% Tween 20 (TBST) and
with monoclonal antibodies (MAb) to MOMP (MAb 4/11) (23, 27) and POMP
(MAb 181) (23, 37), both diluted 1/1,000 in TBST, at room temperature for 1 h.
Bound antibody was detected using horse radish peroxidase-conjugated donkey
anti-sheep immunoglobulin g (IgG) or goat anti-mouse IgG (Sigma-Aldrich Com-
pany Ltd., Poole, United Kingdom) diluted 1/1,000 in TBST with 3,3-diaminoben-
zidine tetrahydrochloride (Sigma ‘Fast’ DAB tablets) as the substrate.
iELISAs. Both the MOMP VS2 and rOMP90-4 iELISAs were performed as
described previously (22). Briefly, 96-well microtiter plates (Immulon; Dynex
Technologies, Ashford, United Kingdom) were coated overnight at 4°C with
antigen at a concentration of 0.1 g of protein/well in 0.1 M sodium carbonate-
bicarbonate buffer (pH 9.6). Odd-numbered rows were coated with GST, and
even-numbered rows were coated with GST-rOMP90-4 or GST-MOMP VS2.
Following three washes with phosphate-buffered saline (pH 7.4)–0.05% Tween
20 (PBST), the plates were blocked with 10% NFDM in bicarbonate buffer for
60 min at 37°C. The plates were washed as before, and then sheep sera (diluted
1:100 in 5% NFDM-PBST) were added to the appropriate wells and the plates
incubated for 60 min at 37°C. After further washing, horseradish peroxidase-
conjugated donkey anti-sheep IgG (diluted 1:1,000 in 5% NFDM-PBST) or
horseradish peroxidase-conjugated rabbit anti-sheep IgM () (Kirkegaard and
Perry Laboratories) was added and incubated for 60 min at 37°C. Bound anti-
body was detected with an o-phenylenediamine peroxidase substrate set (Sigma
Fast o-phenylenediamine dihydrochloride tablet set) according to the manufac-
turer’s instructions (Sigma-Aldrich Company Ltd., Poole, United Kingdom). The
reaction was stopped after 10 min by the addition of 3 M sulfuric acid, and the
absorbance at 492 nm measured on a Labsystems iEMS MF microplate reader
(Thermo Life Sciences, Basingstoke, United Kingdom). Net optical density val-
ues were obtained by subtracting the absorbance values of the GST wells from
the GST-rOMP90-4 or GST-VS2 wells. The cutoff value for both iELISAs was
previously determined to be 0.2.
CFT. The CFT was performed essentially as previously described (35), with
some modifications (2). Samples were tested at twofold dilutions from 1/32 to
1/512. CFT titers were expressed as the highest serum dilution giving 50% or less
hemolysis graded as 2 and 0% as 4. A titer of 4 at 1/32 or greater was
assumed to be positive.
Statistical analysis. Data were analyzed using linear mixed models (6), typi-
cally incorporating pen and animal as random effects and the animal-by-week
interaction as a random effect, where the week component in the within-animal
stratum was modeled using a power model of order 1, based on the time between
observations. Thus, the data were modeled in a way that takes account of the lack
of independence of successive observations from the same animal while also
allowing for the highly unbalanced nature of the data set. Various explanatory
factors were also fitted as fixed effects, such as factors to indicate whether the
animal had been mated, whether the animal had given birth to live young, and
whether the animal had aborted. Week was also included in the model as a fixed
effect, to model any temporal structure in the data which was not explained by
the other explanatory factors. The data were log transformed before analysis to
ensure that the distributional properties were those required for this statistical
analysis. Significance of effects was assessed using Wald tests (6). The small
sample size at the animal stratum and the large autocorrelation observed in the
within-animal stratum necessitated the use of a scaled Wald statistic assessed
against an F distribution, rather than the simpler chi-square test. In each case,
the denominator degrees of freedom for the test was estimated conservatively to
avoid inflation of the type 1 error rate. In many cases, this will have produced an
inflated type 2 error; a less stringent testing criterion would have consistently
produced smaller test P values. The data were analyzed using the Genstat 7th
edition (30).
RESULTS
Clinical outcome and bacteriological results. Experimental
infection of the seven pregnant ewes in group A with C. abortus
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resulted in the birth of six stillborn lambs from three of the
ewes at 3 weeks prior to full term (Table 1). The placentas
recovered from these ewes had macroscopically visible lesions
typical of those seen in chlamydial abortion (21), with 50 to
100% of the area of the placenta affected. Chlamydial bodies
were identified in placental smears and following recovery in
cell culture. The remaining four ewes gave birth to live lambs
around 1 week preterm. In the six placentas recovered from
these animals, most of the placental membranes and cotyle-
dons appeared normal, although two had visible lesions cov-
ering 5 to 20% of the intercotyledonary membrane area. The
presence of chlamydial bodies was confirmed in all tissue sam-
ples taken, other than those from ewe A7, by modified Ziehl-
Neelsen staining of placental smears or by Giemsa staining of
infectious organisms recovered in cell culture.
One of the control ewes in group B (B1), which was housed
with three other animals (Table 1), aborted two fetuses at 18
wg. Macroscopic lesions typical of C. abortus infection were
observed in the one placenta that was recovered, and cell
culture confirmed the presence of chlamydial organisms. The
other control ewes produced live healthy lambs at full term,
and all of the placentas recovered appeared normal, with no
chlamydial organisms detectable in tissue smears or following
recovery in cell culture.
Serological analysis of the infected ewes by iELISA. The
results of the serological analysis of the serum samples col-
lected from each of the infected ewes prior to, throughout, and
after pregnancy with both the recombinant MOMP VS2 and
POMP90-4 iELISAs are shown in Fig. 1. There was a statisti-
cally significant increase in the mean antibody response (total
IgG) to POMP90-4, compared to premating baseline levels, as
early as 1 week after experimental infection (P  0.001). Com-
paring anti-POMP responses postinfection but prelambing or
preabortion, weak statistical evidence suggested that the mean
response in the animals that aborted was lower than that ob-
served in the animals that lambed normally (P  0.06). In
contrast to there being no significant difference between the
mean pre- and postlambing anti-POMP responses (P  0.35),
there was a highly significant increase in mean postabortion
responses compared to preabortion levels (P  0.005), consis-
tent with a reaction to abortion. Following either birth or
abortion, there was no evidence of any significant difference
between the mean responses in the two groups (P  0.94).
In contrast to the anti-POMP responses, there was no im-
mediate statistically significant change in the mean anti-
MOMP responses detectable in infected animals. Rather,
there was evidence of significant differences in the mean re-
sponse in different weeks of the experiment (P  0.01), where
the estimated means consistently increased from week 11 to
week 21. This trend manifested itself as a statistically signifi-
cant (P  0.02) increase in the mean response relative to the
mean week 1 baseline from week 17 onward, 7 weeks after
experimental infection, where the mean response was above
the cutoff threshold for MOMP. The prebirth or preabortion
mean responses in the animals that gave birth were marginally
higher than those in the animals that aborted, but the differ-
ence lacked statistical significance (P  0.50). There was weak
statistical evidence that the ewes that gave birth exhibited
higher mean MOMP responses after birth than before (P 
0.06), but the observed increase in the mean anti-VS2 MOMP
response in observations post- versus preabortion lacked sta-
tistical significance (P  0.21). Responses in animals postabor-
tion were lower than those in animals which gave birth, but
again this difference was not formally statistically significant (P
 0.39). The lack of significance of the results obtained with
the MOMP VS2 iELISA compared to the POMP90-4 iELISA
was a consequence of the fact that two of the ewes that aborted
(A2 and A3) and two of the ewes that gave birth (A6 and A7)
had very little or no anti-VS2 MOMP response (Fig. 1c and d).
Serological analysis of control ewes by iELISA. The pen
containing the ewe that aborted (B1) showed a marked anti-
body response to the POMP antigen prior to abortion, around
which time the antibody levels rose considerably, but also prior
to mating (Fig. 2a). This was in contrast to the anti-VS2
MOMP response (Fig. 2c), which was low prior to abortion and
which did not increase to the same extent as the anti-POMP
TABLE 1. Clinical and bacteriological results for infected and control ewes
Sheep
no.a Treatment group
Length of
gestation (wk)
No. of
lambs
born
No. of
fetuses
aborted
Proportion of placenta
affected (%) Smear or cell culture result
Placenta 1 Placenta 2 Placenta 1 Placenta 2
A1 Infected 18 2 100 100  
A2 Infected 18 2 100 100  
A3 Infected 18 2 50 90  
A4 Infected 19 1 20 NAb  NA
A5 Infected 20 1 5 NA  NA
A6 Infected 20 2 0 0  
A7 Infected 20 2 0 0  
B1 Control 18 2 100 NFc  NA
B2 Control 20 1 0 NA  NA
B3 Control 20 2 0 0  
B4 Control 21 2 0 0  
B5 Control 21 2 0 0  
B6 Control 21 2 0 0  
B7 Control 22 1 0 NA  NA
a The two groups of experimentally infected (group A) and control (group B) ewes were housed into the following subgroups: A1 to A4, A5 to A7, B1 to B4, and
B5 to B7.
b NA, not applicable.
c NF, not found.
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response following abortion. When observations from all ani-
mals were used to parameterize statistical models for baseline
(week 1) anti-VS2 MOMP and anti-POMP responses, the
observations from animal B1 provided extreme outliers in both
models. Hence, observations from animal B1 were anomalous
from the initial stages of the experiment, justifying its removal
from all subsequent statistical analyses. An increasing anti-
POMP antibody titer was detected in another ewe (B2) that
was housed in the same pen, following its lambing at 20 wg
(Fig. 2a). No anti-VS2 MOMP response was detected in this
animal (Fig. 2c). Data from this animal were incorporated into
subsequent analyses, since no consistent pattern of lack of fit
was observed. All other control ewes were negative by both
ELISAs (Fig. 2b and d), with no statistically significant differ-
ences from the baseline occurring in any week for either test.
Detection of IgM antibodies by POMP iELISA. Serum sam-
ples from the challenged ewes, and seroresponsive control ewe
B1, were also tested for the presence of IgM antibodies using
the POMP iELISA (results not shown). POMP-specific anti-
bodies could be detected in ewes A3, A5, A6, and A7 1 week
following infection, although this response was considerably
reduced compared to the IgG response and was short-lived,
returning to prechallenge levels by 2 to 3 weeks postchallenge.
No IgM response could be detected in the other ewes.
EB immunoblot analysis of serum samples. Immunoblotting
with serum samples from the infected ewes against purified EB
lysates demonstrated the presence of anti-POMP antibodies
from 1 week post experimental infection with C. abortus (Fig.
3a to c; Table 2), showing consistency with the POMP90-4
iELISA results. Similarly, the anti-MOMP reactivity observed
on immunoblots generally was consistent with the anti-VS2
MOMP iELISA results (Table 2), where anti-MOMP antibod-
ies could only be detected from the time of abortion or lamb-
ing. Two (A6 and A7) of the three ewes that were negative by
MOMP VS2 iELISA were also negative by immunoblot anal-
ysis (Fig. 3c; Table 2), while the third (A3) was positive by
immunoblotting following abortion (Fig. 3b). Serum from ewe
A2, which had a poor anti-VS2 MOMP response, only exhib-
ited weak reactivity upon immunoblotting (not shown).
Immunoblotting of EBs with serum samples from the con-
trol ewe that aborted (B1) showed weak anti-POMP reactivity
up to 13 weeks into pregnancy but increasing reactivity after
that date, whereas anti-MOMP reactivity was only observed
from around the time of abortion (Fig. 3d). Immunoblot assay
FIG. 1. Comparison of POMP and MOMP iELISA results for the experimentally infected ewes. Sera obtained from C. abortus-infected ewes
(infected at 10 wg) throughout pregnancy were tested by POMP90 (a and b) and MOMP VS2 (c and d) iELISAs. Ewes A1, A2, and A3 aborted
at 18 wg. Ewe A4 lambed at 19 wg, while A5-A7 lambed at 20 wg. For experimental details, see Materials and Methods. OD, optical density.
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results for control ewe B2, which was positive by anti-POMP
(Fig. 2a) but not anti-VS2 MOMP (Fig. 2c) iELISA following
lambing, showed increasing anti-POMP reactivity from 21 wg,
but no anti-MOMP response could be detected (Table 2). All
remaining control animals were negative by both iELISA and
immunoblotting (results not shown).
Immunoblot analysis with recombinant MOMP fragments.
Immunoblotting of the serum samples against each of the four
recombinant MOMP variable segments showed that the anti-
MOMP reactivity of sera observed following immunoblotting
against whole EB lysate was principally directed against the
VS1 and VS2 regions of the protein (Table 2). Only the
MOMP-positive sera from ewe A3 showed no anti-VS2 reac-
tivity by immunoblotting; instead, antibodies were directed
against the VS1 and VS4 regions, confirming the lack of pos-
itivity by VS2 iELISA.
DISCUSSION
In this study we have compared antibody responses through-
out pregnancy, in C. abortus-infected pregnant sheep, to two of
the principal immunodominant antigens, MOMP and
POMP90, present on the surface of the pathogen (23, 25) using
previously developed ELISAs based on recombinant protein
fragments of these proteins (16, 22). The VS2 MOMP iELISA
was shown to behave similarly to the CFT in only detecting a
rise in antibody titer at the time of abortion and lambing.
Furthermore, and again like the CFT, the test lacked sensitivity
as it detected no response or only a very weak response in four
of the seven ewes that were experimentally infected. However,
further analysis showed that for one of these four animals the
antibody response was directed against two of the other sur-
face-exposed variable amino acid sequences or variable seg-
ments of MOMP, namely, VS1 and VS4 (3, 17, 39), rather than
VS2. In addition, one of the other MOMP-negative ewes (A7)
was possible genuinely EAE negative, having cleared the initial
infection, as no organisms could be detected or recovered from
the placenta.
Overall, the humoral responses in the seven animals were
directed principally against VS1 and VS2, with only one animal
having a strong anti-VS4 response. None of the animals had
any anti-VS3 response, perhaps reflecting the identification of
serotype-, subspecies-, and serogroup-specific antigenic deter-
minants in only the VS1, VS2, and VS4 regions of C. tracho-
matis (3, 4). The results of this study imply that any recombi-
FIG. 2. Comparison of POMP and MOMP iELISA results for the control ewes. Sera obtained from the uninfected control ewes throughout
pregnancy were tested by POMP90 (a and b) and MOMP VS2 (c and d) iELISAs. Ewes B1 to B4 were housed separately from ewes B5 to B7.
Ewe B1 aborted at 18 wg, whereas ewe B2 lambed at 20 wg. All other control ewes lambed at 20 to 22 wg (see Table 1). For experimental details,
see Materials and Methods. OD, optical density.
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nant MOMP serological test should be based on both VS1 and
VS2 to maximize the identification of true-positive samples,
although this should be confirmed by testing a larger number
of infected animals. Indeed, a competitive ELISA for diagnos-
ing EAE has also been developed using monoclonal antibodies
to the VS1 and VS2 fragments of C. abortus MOMP (31).
However, even taking this into consideration, three of the
animals had little or no anti-MOMP response. Such variability
in the response to MOMP following abortion has been previ-
ously observed in immunoblotting experiments (19, 25) and
implies that this antigen is not appropriate for screening ani-
mals on an individual basis.
On the other hand, POMP proteins have been suggested to
be serologically important antigens with regard to EAE diag-
nosis as they have been shown to react strongly with sera from
FIG. 3. Immunoblot analysis of serum samples from C. abortus-infected ewes. Serum samples from experimentally infected ewes A1 (a), A3 (b),
and A6 (c) and the seroresponsive control ewe B1 (d) obtained throughout pregnancy were immunoblotted against whole EBs run on a 12%
SDS-polyacrylamide gel. Ewes were challenged at 10 wg (a to c) and either aborted at 18 wg (a, b, and d) or lambed at 20 wg (c). For experimental
details, see Materials and Methods. Molecular masses are indicated on the left. P and M indicate the 90-kDa POMP and 40-kDa MOMP antigens,
respectively (25, 27). This figure was prepared from digital photographic images using CorelDRAW version 9.
TABLE 2. Summary of EB and recombinant MOMP
immunoblot results
Sheep
no.
Treatment
group
EB reactivity to: rMOMP reactivity to:
MOMP POMP VS1 VS2 VS3 VS4
A1 Infected      
A2 Infected Wa     W
A3 Infected      
A4 Infected      W
A5 Infected      
A6 Infected      
A7 Infected      
B1 Control    W  
B2 Control      
a W, weak reactivity.
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C. abortus-infected sheep but not to sera from C. pecorum-
infected animals (14, 32). Furthermore, in contrast to MOMP,
we have observed consistent antibody responses to the highly
immunogenic 90-kDa POMP antigens in all convalescent
sheep serum samples that have been tested, including those in
this study. In addition, and again in contrast to results obtained
with the MOMP iELISA, the POMP iELISA was also found to
detect a humoral response prior to abortion or lambing. In-
deed, the POMP ELISA detected significantly elevated mean
antibody levels as early as 1 week post experimental infection,
corresponding to approximately 77 days of gestation. To our
knowledge, this is the earliest that any serological test has
detected antichlamydial antibodies in pregnant ewes harboring
a primary latent infection. Overall, these results are important
as early diagnosis of a primary infection and the detection of
persistently infected animals, combined with control measures
such as vaccination or antibiotic treatment and improved man-
agement practices at the time of lambing, will reduce the en-
vironmental spread of infection to other susceptible animals.
Ultimately, this will limit financial losses and the possible risks
of zoonotic transmission to humans.
Although the POMP test clearly detects antibody prelamb-
ing or preabortion, this does not necessarily reflect an active
infection. It is possible that the test detects circulating antibody
resulting from the initial infection, which could explain the
results obtained for ewe A7, which was infected but neither
aborted nor had any organisms detectable by smear or culture.
On the other hand, the test does detect variation in the anti-
POMP responses preabortion or prelambing and detects in-
creases in the responses postabortion, which suggests that it
does detect a current infection. Indeed, the antibody response
in ewe A7 steadily declined following initial infection until the
time of lambing and then steadily increased over the remaining
sampling period of the study, suggesting a response to lambing
and reflecting a current infection. Thus, this animal appears to
have had a low-level infection that was not detected in the
small areas of the placenta sampled. However, in general,
while a high or persisting antibody titer does not necessarily
reflect a current or persistent infection, the identification of
positive animals will allow all possible control measures to be
considered. This will be particularly important for screening
replacements prior to introducing them into flocks with no
clinical histories of abortion.
The abortion that occurred in the control group in this study
was unexpected since all animals were prescreened by the CFT
and Western blot analysis before commencing the experiment
and found to be seronegative. This again highlights the lack of
sensitivity of the CFT and the problems that can occur when
using this test to confirm EAE-free status. To eliminate the
possibility of cross-infection, the control ewes were housed
separately from the infected ewes, and both clothing and foot-
wear were changed before entering pens. It is therefore con-
cluded that this ewe was naturally infected prior to selection
for the experiment, possibly during the previous lambing sea-
son. Interestingly, a good anti-POMP response could be de-
tected in this ewe prior to and throughout the first 13 weeks of
pregnancy, in contrast to the very low anti-MOMP response,
suggesting that the POMP test is capable of detecting latently
infected animals. However, this will require further investiga-
tion as these are results from only one animal. In contrast, the
anti-MOMP response was much poorer, only increasing at
around the time of abortion and then gradually declining over
the remaining period of the study. Furthermore, the POMP
ELISA also detected an increasing antibody titer in another
control ewe, which the MOMP ELISA failed to identify. This
ewe must have picked up infection from the ewe (with which it
was housed) that aborted, but this was too late into pregnancy
to result in abortion or in any macroscopic or bacteriological
evidence of infection in the placenta. Seroconversion was also
demonstrated in this ewe by immunoblot analysis following
lambing, but only antibodies to POMP antigens could be de-
tected, consistent with the ELISA results. These results again
highlight the difference in sensitivity between the two ELISAs.
As well as examining the IgG antibody response, we also
investigated the IgM response following primary infection. The
latter, as determined by the POMP90 iELISA, was relatively
weak and rapidly decreased by 2 to 3 weeks postinfection. In
some ewes, no anti-POMP IgM response was detectable. Fu-
ensalida-Draper and Rodolakis (13) suggested that the lack of
a detectable IgM response may be attributable to preexposure
to intestinal chlamydiae. While this is possible, it seems un-
likely, as reinfection would be with a heterologous rather than
a homologous strain. However, as suggested by Papp et al.
(29), the lack of an IgM response may explain why the CFT,
which has an IgM bias, does not reliably detect seropositive
animals.
Thus, in summary, the results presented in this study show
that the POMP90-4 iELISA is more sensitive than either the
CFT or MOMP VS2 iELISA in detecting C. abortus-infected
animals during pregnancy and may also detect antibody in
latently infected animals. These findings, combined with the
previously described results demonstrating the specificity of
the POMP test (22), illustrate the advantages and utility of the
test for controlling the spread of EAE and also limiting the risk
of zoonotic transmission.
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